Open access peer-reviewed chapter - ONLINE FIRST

Comprehensive Epidemiological Insights on Leptospirosis Global Health Effects and the Risk Factors for Prevention and Control

Written By

Aregitu Mekuriaw

Submitted: 07 March 2024 Reviewed: 28 October 2024 Published: 29 April 2025

DOI: 10.5772/intechopen.1008181

Leptospirosis - Symptoms, Causes, Treatment IntechOpen
Leptospirosis - Symptoms, Causes, Treatment Edited by Sara Savic

From the Edited Volume

Leptospirosis - Symptoms, Causes, Treatment [Working Title]

Dr. Sara Savic and Dr. Marina Zekic

Chapter metrics overview

2 Chapter Downloads

View Full Metrics

Abstract

Leptospirosis is a potentially fatal and often ignored zoonotic illness caused by the genus Leptospira. The pathogen infects humans, animals, and ecosystems with diverse clinical signs and is estimated to be responsible for 60,000 mortalities, with over a million cases annually. It is common and poses a significant diagnostic problem in low-income tropical and subtropical countries. The incidence is seasonal; climate change, animal exposure, physical environment, and globalization are risk factors of leptospirosis. Rats are the primary reservoir species, while other mammals may potentially play a major role in the transmission of human illnesses. The high burden of pathogens on animals affects the livestock reproduction sector and impacts the socioeconomic burden. Human leptospirosis commercial vaccines are available in Japan, China, Cuba, and France. The pathogen’s ability to exist in the environment contributes to its growth in water and enables the maintenance and distribution of the bacteria globally. This situation reflects a higher impact on agriculture, human and animal health, and ecosystems, which need comprehensive management and a holistic approach, promoting different disciplines and joint-work initiatives toward controlling and treating leptospirosis. Therefore, this book chapter is aimed at highlighting the leptospirosis disease epidemiology, its global health effects, the risk factors, and the challenges in leptospirosis disease control and prevention.

Keywords

  • epidemiology
  • global
  • leptospirosis
  • prevention
  • zoonosis

1. Introduction

Leptospirosis is the most globally prevalent neglected zoonosis disease that affects both domestic and wild animals, as well as people mainly in low-income populations living in both urban and rural areas of tropical and subtropical regions [1, 2]. Historically, leptospirosis has been linked to occupational threats, upsetting soldiers [3], farmers [4, 5], miners [6], and abattoir workers [7], but individuals in non-specific occupational groups may also get leptospirosis. Thus, with a global distribution, leptospirosis concerns human health and safety at work due to direct or indirect contact with the urine of infected animals and through contaminated water. It can result in life-threatening clinical issues like pulmonary hemorrhage syndrome, which has a high morbidity and mortality rate [8]. Despite having a significant negative impact on human health and livestock production, leptospirosis is a tropical disease that is frequently neglected [9]. Leptospirosis is a zoonosis that has a significant global mortality and morbidity rate and impacts the interface between humans, animals, and ecosystems with several clinical symptoms. It is instigated by the pathogenic spirochete of the genus Leptospira. There is evidence that Leptospira can be found in the tissues of almost all mammal species, and even reptiles and birds may be susceptible to them [10, 11]. Most of the time, an infection has no symptoms at all and is mild, generic, or indiscriminate. But rarely, leptospirosis can cause severe symptoms in both humans and animals that can be life-threatening clinical issues, such as pulmonary hemorrhage syndrome, which has a high morbidity and mortality rate [8, 12].

It is estimated that leptospirosis is responsible for 60,000 deaths annually, with over a million cases reported [13, 14]. However, due to low clinical presentation specificity, lack of diagnostic facility availability, low reliability of surveillance systems, and little knowledge of the disease, these numbers are thought to be significantly underestimated [15]. Effective vaccination is the sole way to avoid it, but since the discovery of bacteria more than a century ago, the leptospirosis vaccine has not advanced significantly [16, 17]. Numerous investigations have revealed that wild animals such as rats, bats, foxes, sea lions, and capybaras are leptospirosis reservoirs [18, 19, 20] and may be spread to people by wild boars, monkeys, and tenrecs [21, 22, 23]. Thus, the identification of animal hosts, which are both direct and indirect infection spreaders, is an essential first step in managing and controlling leptospirosis, regardless of the approach employed, as these animals are the ones that discharge the bacteria into the environment and cause environmental contamination [24]. Among many other considerations, the animal population, environmental circumstances, infectious serovars, accessibility to animals, and species involved can all influence the choice of treatments [25]. Furthermore, leptospirosis still presents several obstacles in underdeveloped nations, encompassing not only public health domains but also medical and biological diagnostics, as well as case management [26]. With varying clinical symptoms, this pathogen affects people, domestic animals, wildlife, and ecosystems. Although, the interplays between domestic animals, wildlife, and humans can occur in a range of locations and are associated with significant epidemics around the globe [27, 28].

Urine from carrier animals can infect humans through direct contact with skin lesions or mucous membranes, while contact with fresh water bodies or irrigated soil polluted by animal urine is more common [14, 17]. Leptospirosis is more frequently associated with leisure and occupational activities in temperate areas; on the other hand, as a result of increased exposure to polluted soil or water because of high rodent populations, the majority of outbreaks in tropical countries happen during the rainy season. More than 35 pathogenic and intermediate Leptospira species, which are mostly spread by environmental factors, are the cause of human leptospirosis [29]. In poor nations from tropical and subtropical locations across the world, leptospirosis has a severe negative impact on vulnerable farming communities. Most animal infections occur through contact with the environment, while some mammal species can frequently contract infections through intercourse. However, the prevalence of infections in animals caused by various Leptospira serovars on livestock farms in tropical and subtropical countries is unknown, which accounts for the lack of standardization and accessibility to diagnostic testing [30]. The high burden of the pathogen on animal’s health affects livestock, the high death rate, the reproduction sector, and the socioeconomic burden [9]. Additionally, they have an impact on the environment because of their widespread distribution and the fact that water promotes the growth, maintenance, transmission, and dispersal of bacteria [31]. Government agencies in charge of leptospirosis treatment and control are promoting a holistic approach, which emphasizes the necessity for inclusive management given the influence on agriculture, human, and animal health [32].

Transmission in vulnerable species is accelerated by epidemiological risk factors, primarily in endemic locations, and includes leisure activities, travel abroad, and occupational exposure. Currently, the way in which Leptospira exposure occurs has changed due to tourism and globalization. As per recent studies [33, 34, 35, 36], leptospirosis is currently seen as a significant danger for travellers. Outdoor recreation and sports have been connected to leptospirosis [37, 38]. Additionally, from the standpoint of individual health, the commercialization of domestic and wild animals in non-endemic regions is a significant factor in the transmission of leptospirosis [9]. Therefore, the discovery of Leptospira reservoirs in wild species provides new information about the epidemiology of the pathogen. Numerous studies have reported that a wide range of serious infectious diseases, such as hanta virus pulmonary syndrome, dengue fever, yellow fever, malaria, trypanosomiasis, leishmaniasis, and leptospirosis, are caused by local climate change, large-scale deforestation, disruption of significant ecosystems and ecosystem services, and urbanization [28]. Furthermore, leptospirosis is an issue for animal health and a source of economic loss in the same underdeveloped areas where the burden of human disease is high; it is acquiescent to One Health approach to intervention [39]. In general, the impact of pathogen backgrounds on agriculture, human health, and animal health discloses the need for inclusive management, where a holistic approach is promoted for controlling and treating leptospirosis. The inclusive management of leptospirosis necessitates a deeper comprehension of the illness and the biological, socioeconomic, and cultural risk factors present in the area. Additionally, as zoonoses are now a growing public health concern, it is critical to support collaborative work projects and provide proof of the necessity for work from a One Health perspective. In this chapter presents an updated, comprehensive epidemiological insight on leptospirosis global health effects and the risk factors for prevention and control.

1.1 Leptospirosis a global zoonotic health effects

A zoonotic bacterial disease, leptospirosis, affects populations with few resources the most, while it can arise in a variety of epidemiological contexts [40, 41]. Because a wide variety of mammals can retain and excrete the spirochete agent from their renal tubules, the disease has a wide geographic spread [41, 42]. Leptospirosis is predicted to be responsible for more than half a million deaths, with over a million cases reported annually [13, 14]. Costa et al.’s [41] more recent estimates indicate that leptospirosis is “among the leading zoonotic causes of morbidity and mortality”. However, according to estimates from the World Health Organization (WHO), there are five endemic cases of human leptospirosis for every 100,000 persons and 14 epidemic cases each year worldwide [43]. These disparate figures demonstrate how challenging it is to quantify the current leptospirosis burden worldwide. This is due to the lack of diagnostic facility availability, low reliability of surveillance systems and little knowledge of the disease, and these numbers are thought to be significantly underestimated [15]. Furthermore, the diagnostic tests that are currently accessible are not ideal; the best tests miss nearly 40% of patients [15]. However, due to low clinical presentation specificity and close similarities to other diseases, only one in ten infections are believed to be precisely identified [44]. Case fatality rates for leptospirosis can vary from less than 5% to more than 30%, depending on the clinical presentation and course of treatment. Young adults between the ages of 20 and 49 are more likely to contract an infection with Leptospira [41]. Males are estimated to bear 80% of the global leptospirosis burden [45]. Leptospirosis, which causes high death rates in both people and sensitive animal species, has become a major infectious zoonotic disease in the last 10 years, especially in endemic tropical locations with significant rainfall [14, 46]. The high death rate in leptospirosis is still high, attributed to a variety of poorly understood factors that may include the innate pathogenicity of some Leptospira strains or host immune-pathological responses that are genetically determined [47]. These factors also contribute to delays in diagnosis brought on by a lack of infrastructure and sufficient clinical suspicion.

In many areas where transmission is endemic, the primary burden attributed to leptospirosis life-threatening manifestations has occurred as a significant cause of acute renal injury related to Weil’s disease [41] and pulmonary hemorrhage syndrome [48]. Moreover, leptospirosis is becoming more widely acknowledged as a significant contributor to undifferentiated fever [49, 50]. Most cases of leptospirosis are misinterpreted as dengue [50, 51], or other acute febrile illness-related conditions. This has been linked to the lack of an appropriate diagnostic test [52], which leads to underreporting of cases [53, 54] and deaths [51]. The absence of trustworthy leptospirosis burden approximations has hindered attempts to build the case for investment in order to remove important obstacles, such as better diagnostics, and find efficient preventive and control strategies. Risk groups for leptospirosis include those working in sewage and abattoirs, military personnel, and people who participate in water sports and recreation, as well as those exposed to animal reservoirs or contaminated surroundings [41]. Furthermore, because of the effects of globalization and climate change, leptospirosis has become a health concern in previously unexplored areas [55, 56]. Epidemics are now known to be glowed by disasters and harsh weather [40, 41].

1.2 Socioeconomic impact of leptospirosis

In addition to the health consequences that leptospirosis might have, the relatives of the victims and society at large may also be negatively impacted financially and socially. The condition has both direct and indirect financial consequences, such as the expense of treating the acute sickness, managing long-term medical issues, causing income loss due to the illness, and maybe having an impact on one’s eventual ability to earn a living [57]. During epidemics, thousands of individuals may possibly become infected in a short period of time, placing a great deal of strain on healthcare services. The health system will be further taxed by the implementation of public health initiatives for surveillance, control, and prevention. Moreover, leptospirosis poses a risk to cattle, exacerbating financial losses. A lot of leptospirosis epidemics happen in urban slums, which are home to some of the most vulnerable and impoverished individuals on the planet. These areas also tend to have low socioeconomic resilience, insufficient access to healthcare, and few public health resources. The combination of these factors will make leptospirosis the most harmful disease to communities in terms of both health and socioeconomics, and as emerging nations become more urbanized, this situation is expected to get worse.

1.3 Leptospirosis epidemiological insights

Leptospirosis is a zoonotic, important bacterial disease that is associated with low levels of sanitation and poverty in both rural and urban regions. Although transmission happens in both developed and developing nations, the occurrence of human infection is greater in tropical regions than in temperate ones. Since the disease is not well-known and tests are not readily available or performed quickly enough, incidence rates are underestimated. In endemic areas, infection that is asymptomatic or subclinical is frequent [58]. It is also interconnected with the locations where livestock is raised, as close contact with animals may facilitate the transmission of leptospirosis. Veterinary professionals, hunters, caregivers of wild animals, farmers, and agricultural workers who come into contact with infected animals are among the people who are affected by this occupational risk disease [59]. Leptospira strains associated with human cases are influenced by the animal reservoir in each particular area. Numerous mammals, such as domestic animals, can preserve and disperse a variety of Leptospira serovars in rural areas [60, 61].

Due to the fact that numerous species can act as reservoirs for illness and are found in tropical, subtropical, and temperate regions, leptospirosis has a complicated epidemiology [62]. Both genders and urban and rural environments report cases of the disease, with young adult males being the most affected [44, 63, 64]. Additionally, it is a significant occupational zoonosis that affects workers in the agricultural, sewage, mining, slaughterhouse, butcher, dairy, veterinary, and animal handling industries, as well as construction, kennel, military, and fishing industries [63, 64, 65]. Teams that work in occupationally exposed environments consider communities living in urban slums with inadequate sanitation to be extremely vulnerable and represent a substantial risk to occupationally exposed personnel [66, 67, 68, 69].

Leptospirosis was mostly a work-related illness in temperate, wealthy nations, linked to exposure to animals or freshwater. It is becoming more widely acknowledged that this environmental illness is linked to leisure pursuits including tramping, rafting, and other outdoor sports [60, 70]. There is evidence that the countries visited pose harm to the environment, and the number of individuals with leptospirosis cases returning from tropical vacations is rising [34, 71]. Leptospirosis is known to occur in both temperate and tropical climates. Research has revealed that the highest frequency of the illness transpired during the rainy seasons in tropical areas and late summer to early fall in temperate countries; nevertheless, the majority of the outbreaks were preceded by times of excessive rainfall where favorable conditions allow for its spread [44, 72, 73]. This is due to warm and moist weather which favors Leptospira existence, and incidences in tropical areas are almost ten times greater than those in temperate areas.

Both global warming and changes in rainfall patterns have the potential to raise the disease burden. For instance, it is a seasonal sickness that is most likely caused by climate change environment (soil or water) contamination in particular as a result of prolonged exposure to an abundance of rodent populations [74, 75, 76, 77]. In areas of moderate climate, work-related and entertaining activities (e.g. contact with polluted water or soil, contact with cattle infected with leptospirosis) are more probable to be linked with leptospirosis [77, 78]. Thus, the population biology, behaviour, or community ecology of spirochetes and their hosts are altered by environmental factors, which have a significant impact on leptospirosis transmission.

1.4 Aetiology of leptospirosis

Leptospira are tiny, helicoidal bacteria with a diameter of 0.1–0.2 μm and a length of 6–20 μm. Two periplasmic flagella are located at each pole of these hooked-ended, gram-negative spirochete bacteria. In addition to aiding in the bacterium’s survival within the host and during infection, flagella allow the bacteria to travel swiftly in viscous environments such as blood, interstitial fluid, and connective tissues [17]. Lipo-polysaccharides, proteins, lipoproteins, and lipids make up the outer membrane, while lipoproteins and transport proteins are in the double-layer inner membrane, which is tightly linked to the peptidoglycan layer [79]. It is believed that having periplasmic flagella and a corkscrew-shaped structure helps Leptospira survive over the long term in both their host and the environment [80]. Leptospira were categorized formerly based on their antigenic patterns, which were grouped into over 25 serogroups that combined serovars that were antigenically linked [58, 81], but, in more recent times, a molecular taxonomy has been reported that uses DNA relatedness to split the Leptospira genus into many species [82]. Leptospira is classified as pathogen, intermediate, or saprophyte strain. Saprophytes are normal inhabitants of many types of wet, humid, and freshwater environments. Pathogen strains can be found in nature in the renal tubules of animals and are notable for their extreme sensitivity to UV radiation, chlorine, and detergents [60, 83]. It is also believed that they are vulnerable to low temperatures and acidic environments.

Almost all mammal species are susceptible to Leptospira infection, which can result in leptospirosis. Intermediates strains can infect mammals, but they often have a lesser virulence and only cause minor illnesses. Pathogenic strains can endure extended periods of time in the environment, but their capacity to multiply outside of their live host is limited. As a response to the prolonged lack of a suitable host species, they instead occasionally display binary fission or, in other situations, group together to form a biofilm [84]. For survival, both saprophyt and pathogen Leptospira need the same kinds of nutrients and temperatures. Saprophyte strains are sometimes discovered in humans and other animals, but they usually live their whole lives in soil and water. In order to finish their life cycles, pathogenic organisms need a live object. However, leptospires’ ability to survive and thrive is mostly dependent on the temperature, pH, and moisture content of their surroundings, in addition to the vital nutrients they need to grow [85, 86]. Leptospira are assumed to be persistent and have an extended lifespan in the environment because of their ability to build biofilms with other bacteria [86].

The majority of settlements use natural water sources like rivers, streams, or subterranean aquifers to gather water, which is then stored in reservoirs for extended periods of time. It is reported worldwide as a threat to epidemics in developing nations during and after the rainy season. People in metropolitan areas are susceptible to leptospirosis when roadways flood after heavy rainfall [87, 88]. There is a significant risk of infection for farmers in rural areas who labour in rice fields [89].

1.5 Leptospirosis infection cycle and transmission

The possibility of contracting leptospirosis is via contact with contaminated environment, infected wild animals, and rodents [60, 61, 68]. Natural reservoirs for Leptospira, such as herbivores and other animals, may develop into symptomless carriers following an infection. As a result, they serve as a significant foundation for Leptospira in the environment through bacteria emissions in urine. Renal carrier state is thought to be the primary mechanism that allows leptospirosis to sustain itself in the environment [90]. The primary carriers of Leptospira are rodents, who can contaminate the environment by releasing the germs through their urine [17]. Many wild and domestic animals, such as bovine, swine, canines, and horses, can serve as reservoirs and contribute to the spread of leptospirosis, but the brown rat has been shown to be the most vital source of human infection [24]. Humans can get sick from direct contact with infected animals and Leptospira contaminated soil and water. Once ingested, the germs penetrate and enter the bloodstream and go to the organs, where they cause pathological harm.

In the past, leptospirosis was mostly thought to be an occupational illness linked to occupations including mining, sewage cleaning, raising and killing livestock, veterinary care, and military operations. With the introduction of preventive measures, the relative significance of certain occupational risks has dropped. Human infection occurs when a person comes into contact with a carrier mammal’s contaminated urine, either directly or through polluted surfaces, water, or soil [91]. Leptospirosis is primarily spread by damaged skin or mucosa when contaminated water, soil, or urine comes into contact with it [92]. Leptospira has never been shown to represent significant epidemiological sources of transmission, despite the fact that humans can excrete them into their urine for weeks, or, in rare cases, months, or longer than a year [24, 60]. In addition, the occurrence of different Leptospira serovars within a human population is influenced by the existence of reservoir animals and the serovars they carry, as well as by local environmental conditions, occupation, agronomical practices, and agricultural methods. People who live in urban areas that are characterized by high population density, poor housing quality, and inadequate cleanliness are more likely to be exposed to rats and consequently contract leptospirosis. In industrialized countries, occupational exposure, visits to endemic regions, leisure activities, and the introduction of both domestic and wild animals are the main causes of infection [24]. For example, a sero-prevalence study conducted by Schoonman and colleagues [93] revealed that, among livestock farmers, veterinary/meat inspectors, and abattoir workers, the prevalence of Leptospira spp. infection was 19.4, 18.1, and 17.1%, respectively. Additionally, subjects who reported milking cows had a significantly higher likelihood of testing positive for the infection [47].

1.6 Pathogenesis and clinical sign

Despite decades of study on leptospirosis, understanding mechanisms of leptospirosis pathogenesis is limited [94]. For example, the cause of the severity or mildness of an infection, whether caused by the pathogen directly or by host immune responses that are genetically defined, is yet unclear [95, 96]. However, the emergence of genetic manipulation instruments and the release of genome sequences from saprophytic and pathogenic Leptospira have recently provided new information about the biology and pathophysiology of this significant agent [97]. Leptospira’s motility and capacity to float through viscous liquids are two virulence mechanisms [98]. The preliminary contagion and the spread of organisms from the site of entrance to end-organ damage locations, including the lung, liver, kidney, eye, and brain, are likely critical processes involving motility. Among the Leptospira genome sequence, there are 4768 predicted genes, at least 50 of which are related to motility [99]. After entering a new host, Leptospira reach the kidneys through the hematogenous route, passing glomeruli or peritubular capillaries. They overrun the brush boundary of the proximal tubule, which is where urine is excreted, when they penetrate the renal tubular lumen [24]. Pathogenic Leptospira can inflict local or systemic harm if it enters the bloodstream. Variations in severity are related to patient age, health state, inoculum size, and serovars [17].

Leptospira incubation lasts approximately 10 days, and the illness manifests 5–14 days following the bacteria’s introduction [100]. A wide range of events may be involved in the acute and chronic infection processes of humans and reservoir hosts, according to the widely varying clinical presentations of Leptospira infection [101]. Leptospira spread quickly and multiplied in the bloodstream during the early phase (3–7 days), after which they went to the kidney, liver, spleen, and other organs [17]. Pathogenic Leptospira infection in hosts results in a wide range of clinical symptoms, including subclinical infection, undifferentiated febrile illness, jaundice, renal failure, and possibly fatal pulmonary hemorrhage [24]. On the other hand, conjunctival suffusion is thought to be a distinctive clinical feature of the early stages of leptospirosis [17]. The proximal renal tubules of carrier animals continue to be colonized, which sustains leptospirosis. An animal that is afflicted may not show any symptoms and may secrete infectious organisms in its urine for the whole of its life [102, 103].

The clinical course of leptospirosis can be split into two phases: the acute phase, marked by flu-like symptoms that are milder, and the chronic phase, which has more severe clinical indications, including renal failure and pulmonary diffuse hemorrhage [100, 104]. In certain instances, the infection may not cause any symptoms. The majority of individuals infected with the pathogen either exhibit few symptoms, such as fever, headache, myalgia, nausea, vomiting, malaise, and conjunctival hyperaemia, or none at all [105]. However, as one of the many potential causes of acute fevers in medical settings, patients experience around 7 days of fever, photophobia, headache, arthralgia, chills, diaphoresis, asthenia, cough, nausea, vomiting, and muscle discomfort that can all manifest during the acute phase of the leptospirosis stage. These symptoms are similar to those of other illnesses like dengue and influenza, which cause misdiagnosis and underreporting of leptospirosis cases worldwide. If treatment is not received, serious forms may develop, resulting in serious pulmonary hemorrhage, liver damage, and renal damage [104]. Leptospirosis motility is likely significant for both the initial infection and the spread of the organisms from the point of entry to end-organ damage sites, including the liver, kidney, brain, lung, and eye [106]. It has been demonstrated that virulent Leptospira strains have a chemotaxis toward haemoglobin [107]. Leptospira also has a variety of putative virulence factors, including phospholipase, sphingomyelinase, and haemolytic activities, which are consistent with their projected capacity to move through host tissues [108].

According to estimates [17], between 10 and 15% of tainted individual’s exhibit major clinical signs, which are more frequent in the late phase (after the first week of infection). However, occasionally, even in the early stages, very severe signs are noted. Weil’s syndrome is the term for the characteristic symptom of the severe form of leptospirosis. Chronic interstitial nephritis, pancreatitis, anemia, splenomegaly, jaundice, renal failure, myocarditis, and pulmonary hemorrhage are among the conditions that these patients may experience [109]. Interstitial nephritis is the key pathological change detected in most cases of patients [110]. According to Ferrer et al. [111], experimental mouse models of Leptospira outer membrane proteins (OMPs) cause local inflammation by stimulating renal cells to produce pro-inflammatory cytokines. Furthermore, one of the most alarming side effects of leptospirosis is severe pulmonary hemorrhage syndrome (SPHS), which is characterized by cough, dyspnoea, haemoptysis, and dense pulmonary hemorrhage as its primary symptoms. About half of the patients with SPHS pass away as a result of these problems [112]. Leptospirosis in cattle is a reproductive disease that is widely known. The main features of this illness include poor offspring’s birth and abortions occurring at any time during a pregnancy. There have been reports of nursing cows’ milk tainted with blood. Conversely, the most typical sign is a silent, on-going infection associated with recurrent estruses and the loss of embryos. Due to their capacity to colonize and bear in the genital tracts of afflicted cows and bulls, serovars Hardjo and Guaricura are more closely linked with the chronic reproductive type of disease. It is becoming well-acknowledged that the main sign of leptospirosis affecting cattle is this genital manifestation of the disease [113, 114, 115].

1.7 Diagnosis and treatment

In endemic areas, leptospirosis infection has a very broad spectrum, which might complicate diagnosis and is frequently asymptomatic or symptomless [68]. As a result, the disease is not as well-known as it could be, and diagnosis is not provided quickly enough or with sufficient accessibility. Leptospirosis is diagnosed depending on the temporal stage of the disease and the sample’s availability. Laboratory techniques such as microscope evaluation, culture, molecular approaches, serology, and animal inoculation are employed to detect Leptospira [116]. Bacterial culture is the gold-standard diagnostic technique, but due to financial and technological constraints, it is not widely used. Nonetheless, epidemiologic investigations of animal strains infecting a particular area need the isolation and genetic characterization of isolates [117, 118]. Thus, an immunoglobulin M (IgM) serological screening approach on a herd level with usually enzyme-linked immune-sorbent assay (ELISA), or MAT may identify suspect herds, but culturing, immunofluorescence, or, preferentially, polymerase chain reaction (PCR) assay is required for a definitive diagnosis in acute phase leptospirosis [91]. Although urine is primary and has been extensively used as a sample, recent studies have demonstrated the usefulness of cervicovaginal mucus for the diagnosis of genital infection. The mortality rate can be significantly decreased by starting antimicrobial medication early and receiving supportive therapy right away [91]. Thus, early detection is essential to lower the severity and rate of disease progression since fast treatment reduces mortality. Leptospira has not shown to have acquired antibiotic resistance, despite slight variations in antibiotic susceptibility among isolates so far [119]. Amoxicillin (or penicillin), tetracycline, or ceftriaxone, doxycycline, streptomycin, and erythromycin are used to treat leptospirosis [60, 72, 120, 121]. Early antibiotic therapy has been shown to reduce the risk of severe disease in both the individual and the population, as well as to reduce the severity and fatality rates and save costs for the healthcare system [60]. Prompt presumptive antibiotic treatment is also advised by the WHO, citing the empirical advantage of starting it prior to the fifth day of illness [72]. The requirements for supportive care, including intensive care, will vary depending on the severity of leptospirosis. The majority of cases of severe leptospirosis will necessitate some kind of supportive care, including intensive care. Hemodynamic instability is often evident in the presentation, necessitating the use of vasoactive medications and intravenous therapy, which will also be employed to administer medication and balance correction. Corticosteroids are occasionally utilized because patients often appear with a septic shock, and some degree of excessive inflammatory response is reported [122].

1.8 Prevention and control measures

The adoption of vaccination is highly recommended since it is the least expensive control strategy and is crucial for the management of leptospirosis [123]. Vaccinating both humans and animals helps prevent leptospirosis. Its effectiveness varies, and research has shown that commercial vaccinations are ineffective at preventing kidney colonization [124]. The effectiveness of the control methods differs depending on the strain of infection. Despite cross-reactivity, some vaccinations may provide protection against serovars, unlike those used to manufacture them [125]. However, their potential serotype dependence and inability to elicit an immunological response against other serovars were noted by Sonrier et al. [126]. Furthermore, the creation of vaccines is hampered by the genetic and phenotypic variety of infective Leptospira [127].

According to Pereira et al. [18], Cuba is the only country in Latin America where people are routinely immunized against Leptospira. Inactivated vaccinations are typically given to domestic animals. It is also used on populations of susceptible people in numerous other nations. But they are not employed everywhere because of unpleasant effects on humans, a lack of cross-protection, and a short duration of immunity [127]. Mostly, the leptospirosis vaccine schedule typically calls for six-month intervals, with the vaccination window falling preferably before the breeding service season, which starts in the early spring when environmental contamination is at its peak [105]. Sejroe strain infections, on the other hand, are impossible to completely eradicate; instead, on-going vigilance and a programme centred on lowering reproductive issues and the ensuing financial risks are necessary [128]. Incidental infections can be managed more readily. The other leptospirosis control techniques are designed to reduce the incidence of clinical disease by implementing integrated actions in many parts of the transmission chain [62, 129].

Advertisement

2. Challenging factors for leptospirosis control and prevention

It is anticipated that leptospirosis risk will increase in the future [24, 41, 56, 60]. Different literature classifications of leptospirosis risk variables include behavioral, climatic, animal exposure, physical, environmental, and socioeconomic threats. Particularly in tropical and subtropical nations, climate change is expected to exacerbate extreme weather conditions and flooding, which could lead to an increase in the frequency of outbreaks [89]. According to research by Dhewantara [130], one of the elements supporting the emergence of leptospirosis’ global dissemination is climate. Some other challenging factors for leptospirosis control and prevention are the biological characteristics of the etiological agent, the reservoir host, and differential diagnosis.

2.1 Biological characteristics of Leptospira as a major challenge

The mechanism of cell aggregation as an endurance technique for leptospires was detected by Trueba et al. [131]. Through the mechanism of cell aggregation, the bacteria can accumulate nutrients and enzymes from the lysing cells, which can help them, survive hard conditions, such as low temperatures or nutrient-poor environments [86, 132]. Leptospira have a double-membrane that is similar to that of gram-negative bacteria due to the presence of lipopolysaccharide (LPS), and their cytoplasmic membrane closely resembles the envelope architecture of Gram-positive bacteria due to the tight interaction of the peptidoglycan cell wall [80]. On the other hand, Leptospira shares a thin peptidoglycan cell wall with other gram-negative bacteria. As noted by Miyamoto-Shinohara et al. [133], the thickness of the cell walls surely affects the survival rate of bacteria. LPS is another characteristic of Leptospira species. By keeping water within the cells, LPS aids in the survival of bacteria in the desiccant environment [134, 135]. For instance, to avoid ice forming inside the cells and moisture build-up during the storage of dried culture, all water must be completely removed from the cell. Accordingly, LPS prevents water molecules from being extracted from inside the cells during the freeze-drying procedure [133]. Because of their meticulous nature, Leptospira spp. are difficult to isolate, propagate, and store [136].

2.2 Diagnostic challenges

Leptospirosis in humans is frequently misdiagnosed and disregarded as the source of fever or generalized sickness. Since it can mimic many other infectious diseases, including dengue, malaria, hepatitis, pneumonia, and meningitis, misdiagnosis is widespread due to its varied symptoms and non-specific presentations. Other illnesses such as haemorrhagic fevers, Q fever, scrub typhus, yellow fever, and rickettsia infections may be included in the differential diagnosis, depending on the patient’s geographic location [137, 138, 139, 140]. Following natural catastrophes, infectious disease epidemics are frequent [138, 139, 140]. Concurrent outbreaks of various pathogens can pose diagnostic hurdles, especially if laboratory facilities are limited. The clinical ramifications of misdiagnosis or delayed diagnosis are noteworthy, as the reduction of morbidity and death associated with early treatment of certain infections like leptospirosis, malaria, and meningitis is imperative. Furthermore, misdiagnosis can cause significant delays in the application of therapies specific to a given disease, giving epidemics the opportunity to “escape.” Following flooding, food- and water-borne diseases are frequent, and some of them might be challenging to distinguish clinically from leptospirosis [89].

Diagnosis is based on laboratory results. However, the clinical appearance of leptospirosis is unclear, and the laboratory diagnosis of leptospirosis is often challenging. The polymerase chain reaction (PCR), which is infrequent in high-endemic areas, is the only sensitive and specific diagnostic that is accurate during the acute phase of the disease [141, 142]. Micro-agglutination testing (MAT), a serological reference approach, is only accessible in Ref. laboratories. Leptospirosis may be mistaken for malaria, influenza, dengue, scrub or murine typhus, spotted fevers, and a variety of other potential viral, parasitic, or bacterial diseases in tropical environments where there are many potential causes for acute fevers [60]. Among hundreds of cases of influenza, dengue, or yellow fever, leptospirosis may be the cause of a few severe cases of fever. As leptospirosis lacks a pathognomonic sign or symptom, samples should be sent to a laboratory for biological study, and the epidemiological perspective should be used to raise suspicions [60, 118]. It has been possible to detect motile, helical-shaped Leptospira bacilli directly in blood or urine; however, this method has been shown to have low sensitivity and is difficult to determine specificity due to the bacteria’s small diameter [44]. Therefore, caution should be exercised while using this technique. These days, genes specific to pathogenic Leptospira are targeted by nucleic acid amplification techniques using a matrix of blood, urine, or cerebrospinal fluid. In order to effectively control this potentially fatal zoonosis, an efficient surveillance system that tracks disease trends must be developed.

Our understanding of the disease will grow with the use of these data, but improving veterinary and public health surveillance and reporting will require more laboratory space and the resolution of diagnostic hurdles by scientists. To full-fill monitoring needs and prevent and reduce leptospirosis epidemics, a collaborative, multidisciplinary One Health approach is required [8]. Early detection of animal sickness could be used to detect environmental pollution and initiate preventive actions to lower the risk of leptospirosis infection in humans [54]. Reducing the opportunities for wild animals to engage with domestic and companion animals, utilizing potable water, immunizing livestock and companion animals, and donning water-proof protection gear and footwear when near potentially polluted water are all possible ways to prevent infection. To determine whether an activity poses a risk of infection for their pet, to learn about infection signs, and to take protective measures in case their pet becomes ill, pet owners should consult with their veterinarian [136].

Organizations dedicated to public and animal health should think about doing educational outreach in places that have recently seen infections in humans or animals, that occasionally flood, and that include recreational water areas or events that could potentially spread the disease. As was previously noted, leptospirosis is primarily found in tropical and subtropical areas, where there are several potential causes of acute fevers. In situations where a hospital has limited space, patient triage may be necessary, particularly in critical care units. This is especially prevalent in two scenarios: either in conjunction with an on-going (usually viral) outbreak or during large-scale leptospirosis outbreaks that follow cyclones [143]. In this specific case of concurrent dengue fevers, leptospirosis should receive extra attention due to its challenging differential diagnosis and the possibility of co-infections [60]. Leptospirosis should receive extra attention in this specific setting of concurrent dengue fevers due to its challenging differential diagnosis, especially given the possibility of co-infections [60]. To find biological indicators with a prognostic value for severity, several clinical investigations involving leptospirosis patients have been carried out. Validated prognostic markers for leptospirosis are still up for debate, despite certain cohorts demonstrating significant differences.

2.3 Animal reservoirs

Animals are traditionally categorized as susceptible or maintenance hosts. Susceptible hosts typically experience a variable-severity illness after infection, which may even be fatal. Within a few weeks, the recuperating hosts will completely eradicate the Leptospira from their bodies. After contagion, vulnerable hosts usually show a course of sickness with a range of severity; sometimes, it may be fatal. The illness varies in severity. Within weeks, the recovered hosts will totally clear their bodies from the Leptospira. With rare exceptions, the maintenance hosts will likely neither acquire nor exhibit any mild clinical symptoms, and they will also likely rid their bodies of Leptospira with the exception of the kidneys, where they will likely continue to grow and persist in the proximal renal tubules for several months.

Preservation host populations are called “reservoirs” for leptospirosis. Among the various Leptospira, different serovars with frequent host associations cattle with the serogroup Hardjo; dogs and canines with the serogroup Canicola; mice with the serogroup Ballum; rats with the serogroup Icterohaemorrhagiae are common. Recent research on the Rattus norvegicus model leptospirosis reservoir has also revealed evidence of Leptospira in the breast tissue and milk of females with long-term infections. Even though it has already been suggested that leptospirosis can spread through breastfeeding [144]. Conditions for the Leptospira strains implicated in individuals’ cases are determined by the animal reservoir in a particular setting. Many mammals in rural areas, such as domestic animals like pigs, cattle, dogs, sheep, and goats, preserve and disperse a variety of Leptospira serovars. Conversely, in typical urban and peri-urban leptospirosis, the main reservoir is rats (mainly Rattus norvegicus) bearing the serogroup Icterohaemorrhagiae. As “vectors,” domestic dogs may, for example, be seen wandering in areas where they come into contact with soil, water, or wild or feral creatures. Within days to weeks, they may become infected and start to excrete leptospires in their urine, even in close proximity to their owners.

2.4 Environmental drivers of leptospirosis

Notwithstanding the prevalence and range of leptospirosis, there are still a great deal of unanswered questions regarding the dynamics of the disease’s transmission and the catalysts for epidemics. However, several environmental risk factors for illness or outbreaks have been found by epidemiological investigations, and these factors vary depending on the ecological area. Urbanization and climate change are probably going to have an impact on a lot of these variables.

2.4.1 The environmental reservoir

Leptospira are released into the environment along with the urine of infected animals. It is believed that pathogen Leptospira exist in the environment but does not proliferate [44, 145]. Early research has identified a few physiological characteristics of Leptospira that influence their ability to survive in the environment [15, 146, 147]. It is commonly known that pathogen Leptospira strain can thrive in neutral to slightly alkaline soils and freshwater environments, such as muck, swamps, streams, lakes, and rivers. Both humans and animals can get infected if they come into contact with that kind of muck or stagnant water. When there is a lot of rain, the surface soils become washed away, exposing humans to pathogenic leptospiras in freshwater bodies like floods. Large-scale outbreaks of leptospirosis typically occur after cyclones or other periods of intense rainfall and flooding [148, 149, 150]. Notably, the continuous changes in climate will likely affect leptospirosis prevalence and distribution in some parts of the world by altering patterns of rainfall [89]. Infection of humans directly from the animal reservoir occurs primarily in work environments. Particularly workers who deal with rodent management, farmers, hunters, butchers, and veterinarians, among other occupations, may come into direct contact with the contaminated urine. Still, data indicates that the majority of human infections are caused by indirect exposure to surface waters, soils, and mud. Occupational exposures among freshwater fishermen, sewage workers, miners, soldiers, farmers, and farmers operating in irrigated rice or taro fields, sugarcane, or banana farms are also accounted for by indirect environmental exposure. Mucosae and skin wounds are entrance points for Leptospira into the body.

2.4.2 Habitats and animal interactions

Habitats that allow for interspecies interactions may promote transmission. Conditions that facilitate interactions between wildlife and farm animals may be produced by agricultural operations. According to New et al., deer frequently consume food that has been left out for cattle [151]. According to Jenkins and associates, swine farms frequently draw stray canines [152]. Among the 30 environments examined, Brown and Gorman conjectured that Leptospira was nearly exclusively found in areas with substantial populations of house mice (Mus musculus) [153]. The increased host susceptibility density could support the persistence of the illness. Domestic cat ownership may benefit human occupants by lowering rodent numbers in residential settings, according to one study [154].

2.4.3 Host and management risk factors

Animals of any age can get a Leptospira infection. While leptospirosis affects almost all mammalian species, it is most frequently found in pigs, dogs, horses, sheep, and goats [62, 155]. Risk factors for infection include the introduction of infected animals into herds, sharing grazing areas with infected animals, contact with infected water sources like rivers, flood waters, or drainage water, and reproduction with infected male animals by natural insemination [156]. Leptospirosis has been linked to animal exposure, especially to rats, rodents, household pets, and livestock, as would be predicted given its route of transmission [24]. The animals that are linked to the spread of disease carry different serovars in different geographical areas; exposure risk is influenced by a number of factors, including living conditions, agricultural activities, local wildlife, and cultural norms.

2.4.4 Climatic change and seasonal factors

The transmission of leptospirosis is frequently seasonal, peaking in warm regions during the rainy seasons and in temperate climates during the summer [12]. Seasonal trends were also identified in veterinary diagnostic studies [157]. Flooding and excessive rains contribute to increasing the threat of leptospirosis. Across the globe, in a variety of geographical locations, there have been numerous reports of leptospirosis outbreaks following extreme weather events [89]. Over the last 50 years, all the scenarios involving greenhouse emissions have resulted in an extraordinary rise in the global surface temperature, and this trend has persisted until the next mid-century [158]. These shifting circumstances can affect hosts, pathogens, vectors, and the spread of disease [159, 160]. In particular, infections can only grow in a limited range of temperatures; they cannot grow at higher or lower temperatures. Higher temperatures hasten the pathogens maturation, which in turn affects the pathogens proliferation and extrinsic incubation duration within a vector.

Climate change poses a number of health risks, and these can be classified as biomedical (i.e. immune-compromised and malnourished), demographic (i.e. age and sex), geographic (i.e. land use and flood zones), socioeconomic (i.e. poverty and education), or socio-political (i.e. civil unrest and political instability) [161].

A weather or climate event can initiate cascading risk pathways, which are a series of secondary, causally connected events, in addition to these effects on infections, vectors, hosts, and disease transmission [160]. In high-risk counties in China, rainfall and land surface temperature were found to be substantially correlated with the notification of human leptospirosis between 2006 and 2016 [162]. Leptospirosis incidences can be brought on by infected drinking water or floodwater [160, 163], clearly demonstrating how population exposure, societal vulnerability, and climatic hazards interact to create cascading risk pathways for leptospirosis.

2.4.5 Rainfall and flooding

The most frequent natural disaster, flooding, can raise the risk of infectious diseases like leptospirosis by interfering with public health services and infrastructure, destroying water and sanitation systems, uprooting populations, causing property damage, and increasing the exposure of the environment to pathogens [89, 164]. The bulk of the world’s most vulnerable populations reside in Asia, the Pacific Islands, Africa, and the Middle East, where 70% of these disasters happen [165]. Rainfall and flooding contribute to the proliferation of rats, the dispersal of food, trash, and debris, the disturbance of sewage and waste management systems, and the promotion of vegetation growth that raises the availability of food [89, 166].

In addition, floods enhance animal-human interaction when people are uprooted from their houses and animals are forced from their customary territories [167].

It is true that intricate socio-ecological processes play a role in leptospirosis transmission. In tropical and subtropical areas, the majority of leptospirosis epidemics happen during the monsoon or humid, wet seasons. These conditions create an ideal environment for Leptospira transmission by bringing in more water, moist soil, and flooding [60, 162]. Certain pathogen Leptospira strains have been shown to survive for days or even months in such favorable environmental circumstances [168, 169]. Additionally, in rural areas, the rainy season coincides with a period of high farming activity (e.g. planting or irrigating paddy fields, harvesting and herding). Simultaneously, the number of mice in the ecosystem grows [170] due to increased rainfall and increased productivity of the land and plants, which in turn provide more food and an environment conducive to rodent breeding. Leptospira shedding into the environment and the risk of transmission among reservoir animals may both increase with a rise in the rodent population. In addition, inadequate waste management, unsanitary practices, and risky behaviors (such as going barefoot) brought on by low socioeconomic circumstances raise the risk of infection in humans [101]. As a consequence, a non-specific clinical presentation may occur, and leptospirosis is frequently misdiagnosed, particularly in areas where scrutiny and analytical abilities are inadequate. Assessing the long-term effects of leptospirosis after floods requires continuous monitoring during the post-disaster phase [166].

Advertisement

3. Temperature

Higher temperatures and humid settings allow Leptospira to live longer, and seasonal variations in leptospirosis incidence are well documented [171, 172]. Increased temperatures can also lessen the availability of surface water due to evaporation while also promoting animal and human water-based activities (such as drinking, swimming, and bathing). This increases the amount of time that people, livestock, pets, and wildlife spend together by sharing the limited surface water sources [89]. The interaction of rainfall, surface runoff, sea level, catchment size, and local terrain is triggered by the consequences of flooding. Land use, urbanization, deforestation, irrigation, agricultural techniques, dams, and water management are some of the ways that these components might change in turn [173]. Increasing sea levels, rising land and sea surface temperatures, a rise in the frequency of hazardous weather events, stronger tropical cyclones, and greater storm surges are additional factors that will increase the danger of floods due to global climate variance [89]. A correlation has also been shown in certain studies [174, 175] between the incidence of leptospirosis and temperature and humidity.

Nowadays, wide ranges of physical environment data at different spatial and temporal scales are delivered by remote-sensing (RS) technologies, which can aid in the understanding of disease epidemiology [176, 177]. In Kampong Cham province, Cambodia, the modified normalized difference water index (MNDWI), which is produced from the Moderate Resolution Imaging Spectroradiometer (MODIS), has been used as a flood indicator and to assess the risk of leptospirosis [178].

Advertisement

4. Conclusions and future prospect

The complexity and variability of leptospirosis epidemiology vary significantly in various environmental settings. The global burden of leptospirosis disease will most likely increase as a result of climate change, flooding, population growth, and urbanization. Understanding disease patterns from an ecological perspective, like the local, regional, and global levels, hence requires. Comprehending the environmental factors that contribute to leptospirosis infection is also crucial for enhancing community awareness and hazard mitigation, as well as developing local capacity to get ready for the rising leptospirosis risk brought on by climate change. More comprehensive surveillance and research are required to better understand leptospirosis transmission patterns and how they may be impacted by climatic events, environmental variables, animal reservoirs, and demographic and socioeconomic trends in humans. Additionally, establishing instruments to determine the causes of outbreaks, create early warning systems, project the frequency and severity of outbreaks, and pinpoint regions most susceptible to a high disease burden can also be important. If such data is available, emergency and disaster response stakeholders could use it to manage risk factors at disaster sites, improve the timeliness of emergency responses, assess the ability of response teams to meet future demands, provide an evidence base for disaster management and public health resource allocation planning and allocation, and concentrate interventions on reducing the risk of infection and the overall disease burden from leptospirosis.

Apart from the existing burden, data indicates that leptospirosis incidence may rise due to climate change, particularly but not exclusively in temperate zones. There is currently no information available on the true cost of this resurgent zoonosis in a number of developing nations with lifestyle, climate, and ecological factors that make leptospirosis likely. It is also likely to be overlooked in many of these nations due to its ambiguous clinical presentation and complex biological diagnosis. Wearing protective gear, such as gloves, eye protection, and face masks, is advised while handling infected animals or working in contaminated regions. Ethiopia and other African nations lack adequate information about leptospirosis. While leptospirosis is easily treatable with most antibiotics, it is also simple to diagnose using microscopy, culture, and serological methods. Antibiotics are an efficient way to treat leptospirosis, and vaccination against the disease can reduce the severity of the illness in domestic animals. The current leptospirosis policies emphasize early case detection and timely treatment. Undoubtedly, this limits mortality and problems in their early stages, but when combined with an integrated rodent management strategy, this can be strengthened even further. It may be helpful to identify risk zones, such as popular tourist destinations, fields, rivers, and streams, and to raise awareness of these areas by highlighting vulnerable populations.

In the upcoming contention for strategy and programme, the integration of rodent control is still lacking in underdeveloped nations, despite an abundance of measures aimed at preventing tropical illnesses that are increasingly being overlooked. Therefore, research is also required to comprehend the potential reservoir due to the variety of causes. The creation of computerized databases, the merging of government and commercial hospitals with academic research groups, and the use of geographic information systems can all be useful in figuring out how the disease is distributed throughout the globe. Frontline healthcare providers may be investigated as a means of educating the public and equipping them with the fundamental knowledge and abilities needed to identify risk factors and report them on time.

Advertisement

Acknowledgments

I want to acknowledge the IntechOpen book chapter organizing for giving me a chance to contribute to this public, livestock, environmental and socioeconomically critical disease for the scientific community.

Advertisement

Conflict of interest

The author declares no conflict of interest.

References

  1. 1. Coppola F, Cilia G, Bertelloni F, Casini L, D’Addio E, Fratini F, et al. Crested porcupine (Hystrix cristata L.): A new potential host for pathogenic Leptospira among semi-fossorial mammals. Comparative Immunology, Microbiology and Infectious Diseases. 2020;70:101472
  2. 2. Agampodi S, Gunarathna S, Lee JS, Excler JL. Global, regional, and country-level cost of leptospirosis due to loss of productivity in humans. PLoS Neglected Tropical Diseases. 2023;17(8):e0011291
  3. 3. Burns DS, Clay KA, Bailey MS. Leptospirosis in a British soldier after travel to Borneo. BMJ Military Health. 2016;162(6):473-475
  4. 4. Lacerda HG, Monteiro GR, Oliveira CC, Suassuna FB, Queiroz JW, Barbosa JD, et al. Leptospirosis in a subsistence farming community in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;102(12):1233-1238
  5. 5. Mgode GF, Japhary MM, Mhamphi GG, Kiwelu I, Athaide I, Machang’u RS. Leptospirosis in sugarcane plantation and fishing communities in Kagera northwestern Tanzania. PLoS Neglected Tropical Diseases. 2019;13(5):e0007225
  6. 6. Yilmaz O, Celebi G, Atabek E, Kokturk F, Atakent SD, Piskin N, et al. Seroprevalence of leptospirosis in coal miners in Zonguldak region/Zonguldak Bolgesinde Komur Madeni Iscilerinde Leptospiroz Seroprevalansi. Klimik Journal. 2019;32(2):174-178
  7. 7. Khaki P, Khodaverdi DE, Moradi BS, Yahaghi H, Dejbord M, Soltani MN. An assay for determining the epidemy of dominant leptospirosis producing serovars among personnel of an industrial slaughter house. Journal of Microbial World. 2012;4(3&4):101-108
  8. 8. Hernández-Rodríguez P, Trujillo-Rojas B. One health: A comprehensive approach to improve prevention and control strategies in leptospirosis. Revista de Ciências Agroveterinárias. 2022;21(1):71-78
  9. 9. Garba B, Bahaman AR, Zakaria Z, Bejo SK, Mutalib AR, Bande F, et al. Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection. Microbial Pathogenesis. 2018;124:136-144
  10. 10. Biscola NP, Fornazari F, Saad E, Richini-Pereira VB, Campagner MV, Langoni H, et al. Serological investigation and PCR in detection of pathogenic leptospires in snakes. Pesquisa Veterinária Brasileira. 2011;31:806-811
  11. 11. Jobbins SE, Alexander KA. Evidence of Leptospira sp. infection among a diversity of African wildlife species: Beyond the usual suspects. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2015;109(5):349-351
  12. 12. Levett PN, Morey RE, Galloway RL, Turner DE, Steigerwalt AG, Mayer LW. Detection of pathogenic Leptospires by real-time quantitative PCR. Journal of Medical Microbiology. 2005;54(1):45-49
  13. 13. Thibeaux R, Girault D, Bierque E, Soupé-Gilbert ME, Rettinger A, Douyère A, et al. Biodiversity of environmental Leptospira: Improving identification and revisiting the diagnosis. Frontiers in Microbiology. 2018;9:816
  14. 14. Karpagam KB, Ganesh B. Leptospirosis: A neglected tropical zoonotic infection of public health importance—An updated review. European Journal of Clinical Microbiology & Infectious Diseases. 2020;39(5):835-846
  15. 15. Warnasekara J, Agampodi S, Abeynayake R, R. Time series models for prediction of leptospirosis in different climate zones in Sri Lanka. PLoS One. 2021;16(5):e0248032
  16. 16. Bashiru G, Bahaman AR. Advances & challenges in leptospiral vaccine development. Indian Journal of Medical Research. 2018;147(1):15-22
  17. 17. Azevedo IR, Amamura TA, Isaac L. Human leptospirosis: In search for a better vaccine. Scandinavian Journal of Immunology. 2023;98(5):e13316
  18. 18. Prager KC, Greig DJ, Alt DP, Galloway RL, Hornsby RL, Palmer LJ, et al. Asymptomatic and chronic carriage of Leptospira interrogans serovar Pomona in California Sea lions (Zalophus californianus). Veterinary Microbiology. 2013;164(1-2):177-183
  19. 19. Dietrich M, Wilkinson DA, Benlali A, Lagadec E, Ramasindrazana B, Dellagi K, et al. L eptospira and paramyxovirus infection dynamics in a bat maternity enlightens pathogen maintenance in wildlife. Environmental Microbiology. 2015;17(11):4280-4289
  20. 20. da Rocha Albuquerque M, dos Reis TA, de Souza Rocha K, da Silva Brito J, de Sena Mesquita GS, da Silva AF, et al. Evidence of exposure to Leptospira spp. in dogs at a zoonosis control center in Brazil. Revista Acadêmica Ciência Animal. 2020;18:1-6
  21. 21. Jansen A, Stark K, Schneider T, Schöneberg I. Sex differences in clinical leptospirosis in Germany: 1997-2005. Clinical Infectious Diseases. 2007;44(9):e69-e72
  22. 22. Dreyfus A, Dyal JW, Pearson R, Kankya C, Kajura C, Alinaitwe L, et al. Leptospira seroprevalence and risk factors in health Centre patients in Hoima District, Western Uganda. PLoS Neglected Tropical Diseases. 2016;10(8):e0004858
  23. 23. Lagadec E, Gomard Y, Le Minter G, Cordonin C, Cardinale E, Ramasindrazana B, et al. Identification of Tenrececaudatus, a wild mammal introduced to Mayotte Island, as a reservoir of the newly identified human pathogenic Leptospira mayottensis. PLoS Neglected Tropical Diseases. 2016;10(8):e0004933
  24. 24. Haake DA, Levett PN. Leptospirosis in humans. Leptospira and Leptospirosis. 2015;387:65-97
  25. 25. Ellis WA. Animal leptospirosis. Leptospira and Leptospirosis. 2015;387:99-137
  26. 26. Guerrant RL, Walker DH, Weller PF. Tropical Infectious Diseases. Pathology. Elsevier Inc.; 2006
  27. 27. Taylor C, Brodbelt DC, Dobson B, Catchpole B, O’neill DG, Stevens KB. Spatio-temporal distribution and agroecological factors associated with canine leptospirosis in Great Britain. Preventive Veterinary Medicine. 2021;193:105407
  28. 28. Nava A, Shimabukuro JS, Chmura AA, Luz SLB. The impact of global environmental changes on infectious disease emergence with a focus on risks for Brazil. ILAR Journal. 2017;58(3):393-400
  29. 29. Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, Melendez AX, et al. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Neglected Tropical Diseases. 2008;2(4):e228
  30. 30. Dung LP, Hai PT, Hoa LM, Mai TNP, Hanh NTM, Than PD, et al. A case–control study of agricultural and behavioral factors associated with leptospirosis in Vietnam. BMC Infectious Diseases. 2022;22(1):583
  31. 31. Bouscaren N, de Coignac CB, Lastère S, Musso D, Teissier Y, Formont J, et al. Leptospirosis in French Polynesia: 11 years of surveillance data, 2007-2017. New Microbes and New Infections. 2019;29:100518
  32. 32. Durski KN, Jancloes M, Chowdhary T, Bertherat E. A global, multi-disciplinary, multi-sectorial initiative to combat leptospirosis: Global leptospirosis environmental action network (GLEAN). International Journal of Environmental Research and Public Health. 2014;11(6):6000-6008
  33. 33. Ricaldi JN, Vinetz JM. Leptospirosis in the tropics and in travelers. Current Infectious Disease Reports. 2006;8:51-58
  34. 34. Bandara M, Ananda M, Wickramage K, Berger E, Agampodi S. Globalization of leptospirosis through travel and migration. Globalization and Health. 2014;10:1-9
  35. 35. De Vries SG, Visser BJ, Stoney RJ, Wagenaar JF, Bottieau E, Chen LH, et al. Leptospirosis among returned travelers: A GeoSentinel site survey and multicenter analysis—1997-2016. The American Journal of Tropical Medicine and Hygiene. 2018;99(1):127
  36. 36. Schönfeld A, Jensen B, Orth HM, Tappe D, Feldt T, Häussinger D. Severe pulmonary haemorrhage syndrome in leptospirosis in a returning traveller. Infection. 2019;47:125-128
  37. 37. Walker MD. Leptospirosis: The possible risk to those participating in water-based sports and activities. British Journal of General Practice. 2018;68(673):394-395
  38. 38. Soo ZMP, Khan NA, Siddiqui R. Leptospirosis: Increasing importance in developing countries. Acta Tropica. 2020;201:105183
  39. 39. Morand S, Jittapalapong S, Kosoy M. Rodents as hosts of infectious diseases: Biological and ecological characteristics. Vector Borne and Zoonotic Diseases. 2015;15(1):1
  40. 40. De Vries SG, Visser BJ, Nagel IM, Goris MG, Hartskeerl RA, Grobusch MP. Leptospirosis in sub-Saharan Africa: A systematic review. International Journal of Infectious Diseases. 2014;28:47-64
  41. 41. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global morbidity and mortality of leptospirosis: A systematic review. PLoS Neglected Tropical Diseases. 2015;9(9):e0003898
  42. 42. Vincent AT, Schiettekatte O, Goarant C, Neela VK, Bernet E, Thibeaux R, et al. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. PLoS Neglected Tropical Diseases. 2019;13(5):e0007270
  43. 43. World Health Organization. Report of the second meeting of the leptospirosis burden epidemiology reference group. 2011
  44. 44. Samrot AV, Sean TC, Bhavya KS, Sahithya CS, Chan-Drasekaran S, Palanisamy R, et al. Leptospiral infection, pathogenesis and its diagnosis—A review. Pathogens. 2021;10(2):145
  45. 45. Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global burden of leptospirosis: Estimated in terms of disability adjusted life years. PLoS Neglected Tropical Diseases. 2015;9(10):e0004122
  46. 46. Pal M, Hadush A. Leptospirosis: An infectious emerging waterborne zoonosis of global significance. Air & Water Borne Diseases. 2017;6(1):1-4
  47. 47. Mteshana ZC. Epidemiology of Leptospirosis in Groote Schuur Hospital. 2021
  48. 48. Samir A, Soliman R, El-Hariri M, Abdel-Moein K, Hatem ME. Leptospirosis in animals and human contacts in Egypt: Broad range surveillance. Revista da Sociedade Brasileira de Medicina Tropical. 2015;48(3):272-277
  49. 49. Wagenaar JF, Gasem MH, Goris MG, Leeflang M, Hartskeerl RA, van der Poll T, et al. Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis. PLoS Neglected Tropical Diseases. 2009;3(6):e453
  50. 50. Biggs HM, Galloway RL, Bui DM, Morrissey AB, Maro VP, Crump JA. Leptospirosis and human immunodeficiency virus co-infection among febrile inpatients in northern Tanzania. Vector-Borne and Zoonotic Diseases. 2013;13(8):572-580
  51. 51. Bruce MG, Sanders EJ, Leake JAD, Zaidel O, Bragg SL, Aye T, et al. Leptospirosis among patients presenting with dengue-like illness in Puerto Rico. Acta Tropica. 2005;96(1):36-46
  52. 52. Musso D, La Scola B. Laboratory diagnosis of leptospirosis: A challenge. Journal of Microbiology, Immunology and Infection. 2013;46(4):245-252
  53. 53. Abela-Ridder B, Sikkema R, Hartskeerl RA. Estimating the burden of human leptospirosis. International Journal of Antimicrobial Agents. 2010;36:S5-S7
  54. 54. Biggs HM, Hertz JT, Munishi OM, Galloway RL, Marks F, Saganda W, et al. Estimating leptospirosis incidence using hospital-based surveillance and a population-based health care utilization survey in Tanzania. PLoS Neglected Tropical Diseases. 2013;7(12):e2589
  55. 55. Garba B, Bahaman AR, Bejo SK, Zakaria Z, Mutalib AR, Bande F. Major epidemiological factors associated with leptospirosis in Malaysia. Acta Tropica. 2018;178:242-247
  56. 56. Bradley EA, Lockaby G. Leptospirosis and the environment: A review and future directions. Pathogens. 2023;12(9):1167
  57. 57. Cristaldi MA, Catry T, Pottier A, Herbreteau V, Roux E, Jacob P, et al. Determining the spatial distribution of environmental and socio-economic suitability for human leptospirosis in the face of limited epidemiological data. Infectious Diseases of Poverty. 2022;11(1):86
  58. 58. Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: A population-based case-control study in the Seychelles (Indian Ocean). International Journal of Epidemiology. 1999;28(3):583-590
  59. 59. Bierque E, Thibeaux R, Girault D, Soupé-Gilbert ME, Goarant C. A systematic review of Leptospira in water and soil environments. PLoS One. 2020;15(1):e0227055
  60. 60. Goarant C. Leptospirosis: Risk factors and management challenges in developing countries. Research and Reports in Tropical Medicine. 2016;28:49-62
  61. 61. López-Robles G, Córdova-Robles FN, Sandoval-Petris E, Montalvo-Corral M. Leptospirosis at human-animal-environment interfaces in Latin-America: Drivers, prevention, and control measures. Biotecnia. 2021;23(3):89-100
  62. 62. Ame MM. Review on Leptospirosis and its public health significance. Veterinary Medicine – Open Journal. 2021;6(2):51-59
  63. 63. Puca E, Pipero P, Harxhi A, Abazaj E, Gega A, Puca E, et al. The role of gender in the prevalence of human leptospirosis in Albania. The Journal of Infection in Developing Countries. 2018;12(03):150-155
  64. 64. Zhang H, Zhang C, Zhu Y, Mehmood K, Liu J, McDonough SP, et al. Leptospirosis trends in China, 2007-2018: A retrospective observational study. Transboundary and Emerging Diseases. 2020;67(3):1119-1128
  65. 65. Matsushita N, Ng CFS, Kim Y, Suzuki M, Saito N, Ariyoshi K, et al. The non-linear and lagged short-term relationship between rainfall and leptospirosis and the intermediate role of floods in the Philippines. PLoS Neglected Tropical Diseases. 2018;12(4):e0006331
  66. 66. Joint, F. A. O., & World Health Organization. Joint WHO/FAO Expert Committee on Zoonoses [Meeting Held in Stockholm from 11 to 16 August 1958]: Second Report. Geneva: World Health Organization; 1959
  67. 67. Mackenzie JS, Jeggo M, Daszak P, Richt JA, editors. One Health: The Human-Animal-Environment Interfaces in Emerging Infectious Diseases, Book Series. Current Topics in Microbiology and Immunology. Vol. 366. Berlin: Springer; 2013
  68. 68. Tilahun Z, Reta D, Simenew K. Global epidemiological overview of leptospirosis. International Journal of Microbiological Research. 2013;4(1):9-5
  69. 69. Galan DI. A Retrospective Study of the Urban and Rural Epidemiological Patterns and the Occupational Risk Groups of Leptospirosis in Brazil. The George Washington University, ProQuest Dissertations & Theses. 2021:2841
  70. 70. Fleuret S. A Back and Forth between Tourism and Health: From Medical Tourism to Global Health. Science Society and New Technology Series Tourism and Mobility Systems set. John Wiley & Sons; 2022
  71. 71. Pakoa JG, Soupé-Gilbert ME, Girault D, Takau D, Gaviga J, Gourinat AC, et al. High incidence of leptospirosis in an observational study of hospital outpatients in Vanuatu highlights the need for improved awareness and diagnostic capacities. PLoS Neglected Tropical Diseases. 2018;12(6):e0006564
  72. 72. World Health Organization. The World Health Report 2003: Shaping the Future. Geneva: World Health Organization; Oct 2003
  73. 73. Lin XA, Chen Y, Yan J. Recombinant multiepitope protein for diagnosis of leptospirosis. Clinical and Vaccine Immunology. 2008;15(11):1711-1714
  74. 74. Verma V, Kala D, Gupta S, Kumar H, Kaushal A, Kuča K, et al. Leptospira interrogans outer membrane protein-based nanohybrid sensor for the diagnosis of leptospirosis. Sensors. 2021;21(7):2552
  75. 75. Joshi YP, Kim EH, Cheong HK. The influence of climatic factors on the development of hemorrhagic fever with renal syndrome and leptospirosis during the peak season in Korea: An ecologic study. BMC Infectious Diseases. 2017;17:1-11
  76. 76. Deshmukh P, Narang R, Jain J, Jain M, Pote K, Narang P, et al. Leptospirosis in Wardha District, Central India—Analysis of hospital based surveillance data. Clinical Epidemiology and Global Health. 2019;7(1):102-106
  77. 77. Desai S, van Treeck U, Lierz M, Espelage W, Zota L, Czerwinski M, et al. Resurgence of field fever in a temperate country: An epidemic of leptospirosis among seasonal strawberry harvesters in Germany in 2007. Clinical Infectious Diseases. 2009;48(6):691-697
  78. 78. Garvey P, Connell J, O'flanagan D, McKeown P. Leptospirosis in Ireland: Annual incidence and exposures associated with infection. Epidemiology & Infection. 2014;142(4):847-855
  79. 79. Zachary JF. Mechanisms of microbial infections. Pathologic Basis of Veterinary Disease. 2017;132:241
  80. 80. Mohammed H, Nozha C, Hakim K, Abdelaziz F, Rekia B. Leptospira: Morphology, classification and pathogenesis. Journal of Bacteriology & Parasitology. 2011;2(06):1-4
  81. 81. Fouts DE, Matthias MA, Adhikarla H, Adler B, Amorim-Santos L, Berg DE, et al. What makes a bacterial species pathogenic?: Comparative genomic analysis of the genus Leptospira. PLoS Neglected Tropical Diseases. 2016;10(2):e0004403
  82. 82. Adler B, Lo M, Seemann T, Murray GL. Pathogenesis of leptospirosis: The influence of genomics. Veterinary Microbiology. 2011;153(1-2):73-81
  83. 83. Cordonin C, Turpin M, Bringart M, Bascands JL, Flores O, Dellagi K, et al. Pathogenic Leptospira and their animal reservoirs: Testing host specificity through experimental infection. Scientific Reports. 2020;10(1):7239
  84. 84. Evangelista KV, Coburn J. Leptospira as an emerging pathogen: A review of its biology, pathogenesis and host immune responses. Future Microbiology. 2010;5(9):1413-1425
  85. 85. Barragan V, Olivas S, Keim P, Pearson T. Critical knowledge gaps in our understanding of environmental cycling and transmission of Leptospira spp. Applied and Environmental Microbiology. 2017;83(19):e01190-e01117
  86. 86. Philip N, Garba B, Neela VK. Long-term preservation of Leptospira spp.: Challenges and prospects. Applied Microbiology and Biotechnology. 2018;102:5427-5435
  87. 87. Mutoh Y, Koizumi N, Morino E, Hayakawa K, Kato Y, Ohmagari N. Leptospirosis cases in the Tokyo metropolitan area, Japan. Japanese Journal of Infectious Diseases. 2017;70(6):669-671
  88. 88. Cunha M, Costa F, Ribeiro GS, Carvalho MS, Reis RB, Nery N Jr, et al. Rainfall and other meteorological factors as drivers of urban transmission of leptospirosis. PLoS Neglected Tropical Diseases. 2022;16(4):e0007507
  89. 89. Lau CL, Smythe LD, Craig SB, Weinstein P. Climate change, flooding, urbanisation and leptospirosis: Fuelling the fire? Transactions of the Royal Society of Tropical Medicine and Hygiene. 2010;104(10):631-638
  90. 90. Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Veterinary Microbiology. 2010;140(3-4):287-296
  91. 91. Lane AB, Dore MM. Leptospirosis: A clinical review of evidence based diagnosis, treatment and prevention. World Journal of Clinical Infectious Diseases. 2016;6(4):61-66
  92. 92. Al-Orry W, Arahou M, Hassikou R, Charof R, Qasmaoui A, Ouanaim C, et al. Serodiagnosis of human leptospirosis by enzyme linked immunosorbent assay (ELISA). Australasian Medical Journal (Online). 2017;10(1):30
  93. 93. Schoonman L, Swai ES. Risk factors associated with the seroprevalence of leptospirosis, amongst at-risk groups in and around Tanga city, Tanzania. Annals of Tropical Medicine & Parasitology. 2009;103(8):711-718
  94. 94. Faisal SM, McDonough SP, Chang YF. Leptospira: Invasion, pathogenesis and persistence. In: The Pathogenic Spirochetes: Strategies for Evasion of Host Immunity and Persistence. 2012. pp. 143-172
  95. 95. Monahan AM, Miller IS, Nally JE. Leptospirosis: Risks during recreational activities. Journal of Applied Microbiology. 2009;107(3):707-716
  96. 96. Chin VK, Lee TY, Lim WF, Ywy WS, Syafinaz AN, Zamberi S, et al. Leptospirosis in human: Biomarkers in host immune responses. Microbiological Research. 2018;207:108-115
  97. 97. Bulach D, Adler B. Leptospiral genomics and pathogenesis. Spirochete Biology: The Post Genomic Era. 2018;415:189-214
  98. 98. Faine S. Leptospira and leptospirosis. USA: CRC Press Inc; 1994
  99. 99. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature. 2003;422(6934):888-893
  100. 100. Wynwood SJ. Advancing leptospirosis diagnostics in human and animal systems [Doctoral dissertation]. University of the Sunshine Coast. 2015
  101. 101. Mwachui MA, Crump L, Hartskeerl R, Zinsstag J, Hattendorf J. Environmental and behavioural determinants of leptospirosis transmission: A systematic review. PLoS Neglected Tropical Diseases. 2015;9(9):e0003843
  102. 102. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: A zoonotic disease of global importance. The Lancet Infectious Diseases. 2003;3(12):757-771
  103. 103. Al-orry W, Arahou M, Hassikou R, Quasmaoui A, Charof R, Mennane Z. Leptospirosis: Transmission, diagnosis and prevention. International Journal of Innovation and Applied Studies. 2016;15(3):457
  104. 104. Chacko CS, Jayakumar A, Binu SL, Pant RD, Giri A, Chand S, et al. A short review on leptospirosis: Clinical manifestations, diagnosis and treatment. Clinical Epidemiology and Global Health. 2021;11:100741
  105. 105. Fraga TR, Carvalho E, Isaac L, Barbosa AS. Leptospira and leptospirosis. In: Molecular medical microbiology. 3rd edition. Academic Press; 2024. pp. 1849-1871
  106. 106. Togal T, Sener A, Yucel N, Demirbilek S, Akgun FS, Aydogan M, et al. Intensive care of a Weil's disease with multiorgan failure. Journal of Clinical Medicine Research. 2010;2(3):145
  107. 107. Murray GL. The molecular basis of leptospiral pathogenesis. Leptospira and Leptospirosis. 2014;12:139-185
  108. 108. Ashaiba A, Arun AB, Prasad KS, Tellis RC. Leptospiral sphingomyelinase Sph2 as a potential biomarker for diagnosis of leptospirosis. Journal of Microbiological Methods. 2022;203:106621
  109. 109. Charles JC, Jayarajah U, Subasinghe D. Clinical characteristics and outcomes of patients with leptospirosis complicated with acute pancreatitis: A systematic review. Journal of International Medical Research. 2023;51(9):03000605231197461
  110. 110. Seguro AC, Andrade L. Pathophysiology of leptospirosis. Shock. 2013;39:17-23
  111. 111. Ferrer MF, Scharrig E, Alberdi L, Cedola M, Pretre G, Drut R, et al. Decay-accelerating factor 1 deficiency exacerbates leptospiral-induced murine chronic nephritis and renal fibrosis. PLoS One. 2014;9(7):e102860
  112. 112. Bharu K. Risk and prognostic factors for severe leptospirosis in adult population in intensive care unit hospital raja Perempuan Zainab II [Doctoral dissertation]. Universiti Sains Malaysia; 2017
  113. 113. Martins G, Lilenbaum W. Control of bovine leptospirosis: Aspects for consideration in a tropical environment. Research in Veterinary Science. 2017;112:156-160
  114. 114. Loureiro AP, Lilenbaum W. Genital bovine leptospirosis: A new look for an old disease. Theriogenology. 2020;141:41-47
  115. 115. Aliberti A, Blanda V, Di Marco Lo Presti V, Macaluso G, Galluzzo P, Bertasio C, et al. Leptospira interrogans Serogroup Pomona in a dairy cattle farm in a multi-host Zootechnical system. Veterinary Sciences. 2022;9(2):83
  116. 116. Christopher-Hennings J, Erickson GA, Hesse RA, Nelson EA, Rossow S, Scaria J, et al. Diagnostic tests, test performance, and considerations for interpretation. Diseases of Swine. 2019;3:75-97
  117. 117. Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA. Rapid tests for diagnosis of leptospirosis: Current tools and emerging technologies. Diagnostic Microbiology and Infectious Disease. 2014;78(1):1-8
  118. 118. Sykes JE, Gamage CD, Haake DA, Nally JE. Understanding leptospirosis: Application of state-of-the-art molecular typing tools with a one health lens. American Journal of Veterinary Research. 2022;83(10):1-8
  119. 119. Trott DJ, Abraham S, Adler B. Antimicrobial resistance in Leptospira, Brucella, and other rarely investigated veterinary and zoonotic pathogens. Microbiology Spectrum. 2018;6(4):10-1128
  120. 120. Heymann DL, Dixon M. Infections at the animal/human interface: Shifting the paradigm from emergency response to prevention at source. In: One Health: The Human-Animal-Environment Interfaces in Emerging Infectious Diseases: Food Safety and Security, and International and National Plans for Implementation of One Health Activities. 2013. pp. 207-215
  121. 121. Davis LI. Winter bird census at Xilitla, San Luis Potosí, Mexico. The Condor. 1952;54(6):345-355
  122. 122. Smith S, Kennedy BJ, Dermedgoglou A, Poulgrain SS, Paavola MP, Minto TL, et al. A simple score to predict severe leptospirosis. PLoS Neglected Tropical Diseases. 2019;13(2):e0007205
  123. 123. Pereira MM, Schneider MC, Munoz-Zanzi C, Costa F, Benschop J, Hartskeerl R, et al. A road map for leptospirosis research and health policies based on country needs in Latin America. Revista Panamericana de Salud Pública. 2017;41:e131
  124. 124. Barazzone GC, Teixeira AF, Azevedo BO, Damiano DK, Oliveira MP, Nascimento AL, et al. Revisiting the development of vaccines against pathogenic Leptospira: Innovative approaches, present challenges, and future perspectives. Frontiers in Immunology. 2022;12:760291
  125. 125. Matsuo K, Isogai E, Araki Y. Control of immunologically crossreactive leptospiral infection by administration of lipopolysaccharides from a nonpathogenic strain of Leptospira biflexa. Microbiology and Immunology. 2000;44(11):887-890
  126. 126. Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine. 2000;19(1):86-94
  127. 127. Grassmann AA, Souza JD, McBride AJA. A universal vaccine against leptospirosis: Are we going in the right direction? Frontiers in Immunology. 2017;8:256
  128. 128. Suepaul SM, Carrington CVF, Campbell M, Borde G, Adesiyun AA. Serovars of Leptospira isolated from dogs and rodents. Epidemiology & Infection. 2010;138(7):1059-1070
  129. 129. Lucheis SB, Ferreira RS Jr. Ovine leptospirosis in Brazil. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2011;17:394-405
  130. 130. Dhewantara P. Spatial Epidemiological Approaches to Monitor and Measure the Risk of Human Leptospirosis. 2020
  131. 131. Trueba G, Zapata S, Madrid K, Cullen P, Haake D. Cell aggregation: A mechanism of pathogenic Leptospira to survive in fresh water. International Microbiology. 2004;7(1):35-40
  132. 132. Rabozzi G, Bonizzi L, Crespi E, Somaruga C, Sokooti M, Tabibi R, et al. Emerging zoonoses: The “one health approach”. Safety and Health at Work. 2012;3(1):77-83
  133. 133. Miyamoto-Shinohara Y, Sukenobe J, Imaizumi T, Nakahara T. Survival of freeze-dried bacteria. The Journal of General and Applied Microbiology. 2008;54(1):9-24
  134. 134. Patra KP, Choudhury B, Matthias MM, Baga S, Bandyopadhya K, Vinetz JM. Comparative analysis of lipopolysaccharides of pathogenic and intermediately pathogenic Leptospira species. BMC Microbiology. 2015;15:1-11
  135. 135. Billi D, Potts M. Life and death of dried prokaryotes. Research in Microbiology. 2002;153(1):7-12
  136. 136. Zuerner RL, Trueba GA. Characterization of IS 1501 mutants of Leptospira interrogans serovar Pomona. FEMS Microbiology Letters. 2005;248(2):199-205
  137. 137. Boggild AK, Liles WC. Travel-acquired illnesses associated with fever. The Travel and Tropical Medicine Manual. 2017;271:99
  138. 138. Bhargava A, Ralph R, Chatterjee B, Bottieau E. Assessment and initial management of acute undifferentiated fever in tropical and subtropical regions. BMJ. 2018;363:145-152
  139. 139. Ashley E, Bern C, Borok M, Brotherton B, Chappuis F, Chung C, et al. Multisystem diseases and infections. Oxford Medical Handbooks. 5th ed. Oxford University Press; 2021:673-766
  140. 140. Munoz-Zanzi C, Groene E, Morawski BM, Bonner K, Costa F, Bertherat E, et al. A systematic literature review of leptospirosis outbreaks worldwide, 1970-2012. Revista Panamericana de Salud Pública. 2020;44:e78
  141. 141. Walika M, De Almeida MM, Delgado RC, González PA. Outbreaks following natural disasters: A review of the literature. Disaster Medicine and Public Health Preparedness. 2023;17:e444
  142. 142. Khan F, Mahtab M, Ahmad N, Shukla I, Rizvi M, Azam M, et al. Rapid diagnosis of leptospirosis by IgM ELISA in resource poor settings. International Journal of Health Sciences & Research. 2016;6(3):73-79
  143. 143. Blessington T, Schenck AP, Levine JF. A systemic review of the frequency of animal leptospirosis in the southern United States and the implications for human health. Southern Medical Journal. 2020;113(5):240-249
  144. 144. De Oliveira D, Figueira CP, Zhan L, Pertile AC, Pedra GG, Gusmão IM, et al. Leptospira in breast tissue and milk of urban Norway rats (Rattus norvegicus). Epidemiology & Infection. 2016;144(11):2420-2429
  145. 145. Stone NE, Hall CM, Ortiz M, Hutton SM, Santana-Propper E, Celona KR, et al. Diverse lineages of pathogenic Leptospira species are widespread in the environment in Puerto Rico, USA. PLoS Neglected Tropical Diseases. 2022;16(5):e0009959
  146. 146. Barcellos C, Sabroza PC. The place behind the case: Leptospirosis risks and associated environmental conditions in a flood-related outbreak in Rio de Janeiro. Cadernos De Saude Publica. 2001;17:S59-S67
  147. 147. Liverpool J, Francis S, Liverpool CE, Dean GT, Mendez DD. Leptospirosis: Case reports of an outbreak in Guyana. Annals of Tropical Medicine & Parasitology. 2008;102(3):239-245
  148. 148. Supe A, Khetarpal M, Naik S, Keskar P. Leptospirosis following heavy rains in 2017 in Mumbai: Report of large-scale community chemoprophylaxis. The National Medical Journal of India. 2018;31(1):19-21
  149. 149. Kakalou E, Tsiamis C. Infectious diseases outbreaks following natural disasters: Risk assessment, prevention, and control. In: Emergency Medicine, Trauma and Disaster Management: From Prehospital to Hospital Care and beyond. Cham: Springer International Publishing; 2021. pp. 525-535
  150. 150. Mugabe VA, Inlamea OF, Ali S, Maholela P, Melchior B, Muianga AF, et al. Surveillance for arboviruses and leptospirosis among non-malarial acute febrile illness outpatients in areas affected by cyclones Idai and Kenneth in Mozambique. Frontiers in Tropical Diseases. 2023;4:1091545
  151. 151. Mitchell B, Staines BW, Welch D. Ecology of Red Deer: A Research Review Relevant to their Management in Scotland. Institute of Terrestrial Ecology. Natural Environment Research Council. 1977
  152. 152. Jenkins JC. The Politics of Insurgency. The Farm Worker Movement in the 1960s. New York Chichester, West Sussex: Columbia University Press; 1985
  153. 153. Brown RZ, Gorman GW. The occurrence of leptospiral infections in feral rodents in southwestern Georgia. American Journal of Public Health and the Nations Health. 1960;50(5):682-688
  154. 154. Childs CW. Ferrihydrite: A review of structure, properties and occurrence in relation to soils. Zeitschrift für Pflanzenernährung und Bodenkunde. 1992;155(5):441-448
  155. 155. Levett PN. Systematics of leptospiraceae. Leptospira and Leptospirosis. 2015;387:11-20
  156. 156. Constable PD, Hinchcliff KW, Done SH, Grünberg W. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. Elsevier Health Sciences; Veterinary Medicine: Ed:11. Vol. 1. 2016
  157. 157. Ward T. Good lives and the rehabilitation of offenders: Promises and problems. Aggression and Violent Behavior. 2002;7(5):513-528
  158. 158. Forster PM, Smith CJ, Walsh T, Lamb WF, Lamboll R, Hauser M, et al. Indicators of global climate change 2022: Annual update of large-scale indicators of the state of the climate system and human influence. Earth System Science Data. 2023;15(6):2295-2327
  159. 159. Wu X, Lu Y, Zhou S, Chen L, Xu B. Impact of climate change on human infectious diseases: Empirical evidence and human adaptation. Environment International. 2016;86:14-23
  160. 160. Semenza JC, Rocklöv J, Ebi KL. Climate change and cascading risks from infectious disease. Infectious Diseases and Therapy. 2022;11(4):1371-1390
  161. 161. Crimmins EM, Zhang Y, Saito Y. Trends over 4 decades in disability-free life expectancy in the United States. American Journal of Public Health. 2016;106(7):1287-1293
  162. 162. Dhewantara PW, Hu W, Zhang W, Yin WW, Ding F, Al Mamun A, et al. Climate variability, satellite-derived physical environmental data and human leptospirosis: A retrospective ecological study in China. Environmental Research. 2019;176:108523
  163. 163. Dechet AM, Parsons M, Rambaran M, Mohamed-Rambaran P, Florendo-Cumbermack A, Persaud S, et al. Leptospirosis outbreak following severe flooding: A rapid assessment and mass prophylaxis campaign; Guyana, January-February 2005. PLoS One. 2012;7(7):e39672
  164. 164. Patz JA, Frumkin H. Climate change and human health. In: Environmental Health: From Global to Local. 2016. p. 275
  165. 165. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326(5960):1694-1697
  166. 166. Cook A, Watson J, Van Buynder P, Robertson A, Weinstein P. 10th anniversary review: Natural disasters and their long-term impacts on the health of communities. Journal of Environmental Monitoring. 2008;10(2):167-175
  167. 167. Gubler DJ, Reiter P, Ebi KL, Yap W, Nasci R, Patz JA. Climate variability and change in the United States: Potential impacts on vector-and rodent-borne diseases. Environmental Health Perspectives. 2001;109(Suppl. 2):223-233
  168. 168. Andre-Fontaine G, Aviat F, Thorin C. Waterborne leptospirosis: Survival and preservation of the virulence of pathogenic Leptospira spp. in fresh water. Current Microbiology. 2015;71:136-142
  169. 169. Baker HG, Baker I. Amino-acids in nectar and their evolutionary significance. Nature. 1973;241(5391):543-545
  170. 170. Perez J, Brescia F, Becam J, Mauron C, Goarant C. Rodent abundance dynamics and leptospirosis carriage in an area of hyper-endemicity in New Caledonia. PLoS Neglected Tropical Diseases. 2011;5(10):e1361
  171. 171. Desvars A, Jégo S, Chiroleu F, Bourhy P, Cardinale E, Michault A. Seasonality of human leptospirosis in Reunion Island (Indian Ocean) and its association with meteorological data. PLoS One. 2011;6(5):e20377
  172. 172. Nau LH, Obiegala A, Król N, Mayer-Scholl A, Pfeffer M. Survival time of Leptospira kirschneri serovar Grippotyphosa under different environmental conditions. PLoS One. 2020;15(7):e0236007
  173. 173. McMichael AJ, Woodruff RE, Hales S. Climate change and human health: Present and future risks. The Lancet. 2006;367(9513):859-869
  174. 174. Joshi BK. Conservation and utilization of agro-biodiversity advanced from 1937 to 2017 in Nepal. In: Devkota F, editor. Krishi Sanchar Smarika. Khumaltar, Nepal: Agricultural Information and Communication Center (AICC), MoAD; 2017. pp. 181-208
  175. 175. Sumi A, Telan EFO, Chagan-Yasutan H, Piolo MB, Hattori T, Kobayashi N. Effect of temperature, relative humidity and rainfall on dengue fever and leptospirosis infections in Manila, the Philippines. Epidemiology & Infection. 2017;145(1):78-86
  176. 176. Estrela VV, Aroma J, Sroufer R, Raimond K, Intorne AC, Deshpande A, et al. Remote sensing applications in disease mapping and public health analysis. In: Intelligent Healthcare Systems. 1st edition. CRC Press; 2023. pp. 185-202
  177. 177. Herbreteau V, Demoraes F, Khaungaew W, Hugot JP, Gonzalez JP, Kittayapong P, et al. Use of geographic information system and remote sensing for assessing environment influence on leptospirosis incidence, Phrae province, Thailand. International Journal of Geoinformatics. 2006;2(4):43-50
  178. 178. Ledien J, Sorn S, Hem S, Huy R, Buchy P, Tarantola A, et al. Assessing the performance of remotely-sensed flooding indicators and their potential contribution to early warning for leptospirosis in Cambodia. PLoS One. 2017;12(7):e0181044

Written By

Aregitu Mekuriaw

Submitted: 07 March 2024 Reviewed: 28 October 2024 Published: 29 April 2025